Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Cited by (1,002)

Items 301–400 of 1,002

1. COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department
   Mathias Van Singer, Thomas Brahier, Michelle Ngai, Julie Korol Wright, Andrea M. Weckman, Clara Erice, Jean‐Yves Meuwly, Olivier Hügli, Kevin C. Kain, Noémie Boillat‐Blanco · 2020 · Journal of Allergy and Clinical Immunology
2. COVID‐19‐induced endotheliitis: emerging evidence and possible therapeutic strategies
   Eleonora Calabretta, Jose Maria Moraleda, Massimo Iacobelli, Rubén Jara, Israël Vlodavsky, Peter O’Gorman, Antonio Pagliuca, Clifton Craig Mo, Rebecca Marlene Baron, Alessio Aghemo et al. · 2021 · British Journal of Haematology
3. Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID‐19 Cytokine Storm
   Qian‐Fang Meng, Rui Tian, Haiyi Long, Xianjia Wu, Jialin Lai, Olga Zharkova, Jiong‐Wei Wang, Xiaoyuan Shawn Chen, Lang Rao · 2021 · Advanced Materials
4. The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection
   Muhammad Suhaib Qudus, Mingfu Tian, Summan Sirajuddin, Siyu Liu, Uzair Afaq, Muneeba Wali, Jinbiao Liu, Pan Pan, Zhen Luo, Qiwei Zhang et al. · 2023 · Journal of Medical Virology
5. Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID
   Clough, Erin, Inigo, Joseph, Chandra, Dhyan, Chaves, Lee, Reynolds, Jessica L., Aalinkeel, Ravikumar, Schwartz, Stanley A., Khmaladze, Alexander, Mahajan, Supriya D. · 2021 · Journal of Neuroimmune Pharmacology
6. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19
   Olivier Demaria, Julien Carvelli, Luciana Batista, Marie‐Laure Thibult, Ariane Morel, Pascale André, Yannis Morel, Frédéric Vely, Éric Vivier · 2020 · Cellular and Molecular Immunology
7. Leptin correlates with monocytes activation and severe condition in COVID-19 patients
   Jingya Wang, Yinyin Xu, Xiaoli Zhang, Sheng Wang, Ziyi Peng, Jing Ru Guo, Hongmei Jiang, Jing Liu, Ying Xie, Jingjing Wang et al. · 2021 · Journal of Leukocyte Biology
8. Dynamic changes in serum IL-6, IL-8, and IL-10 predict the outcome of ICU patients with severe COVID-19
   Jia Li, Rong Liu, Ran Cui, Jiaqi Feng, Yuyang Jin, Yuetian Yu, Xiaoxiang Chen, Renying Xu · 2021 · Annals of Palliative Medicine
9. Plasmodium falciparum malaria drives epigenetic reprogramming of human monocytes toward a regulatory phenotype
   Rajan Guha, Anna Mathioudaki, Safiatou Doumbo, Didier Doumtabé, Jeff Skinner, Gunjan Arora, Shafiuddin Siddiqui, Shanping Li, Kassoum Kayentao, Aïssata Ongoïba et al. · 2021 · PLoS Pathogens
10. Antiviral and Virucidal Properties of Essential Oils and Isolated Compounds – A Scientific Approach
    Jürgen Reichling · 2021 · Planta Medica
11. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19
    Gunawan Widjaja, Abduladheem Turki Jalil, Heshu Sulaiman Rahman, Walid Kamal Abdelbasset, Dmitry Olegovich Bokov, Wanich Suksatan, Mahnaz Ghaebi, Faroogh Marofi, Jamshid Gholizadeh Navashenaq, Farhad Jadidi‐Niaragh et al. · 2021 · Human Immunology
12. Musculoskeletal symptoms and related factors in postacute COVID‐19 patients
    Fulya Bakılan, İsmail Güneş Gökmen, Burcu Ortanca, Anıl Uçan, Şebnem Eker Güvenç, Fezan Mutlu, Hatice Merve Gökmen, Ayşe Aydemir Ekim · 2021 · International Journal of Clinical Practice
13. Spatiotemporal Adaptations of Macrophage and Dendritic Cell Development and Function
    Antoine Roquilly, Justine D. Mintern, Jóse A. Villadangos · 2022 · Annual Review of Immunology
14. Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery
    Zhao Gan, Lulu Xue, Hannah C. Geisler, Junchao Xu, Xinyuan Li, Michael J. Mitchell, Andrew E. Vaughan · 2024 · Proceedings of the National Academy of Sciences
15. Macrophage Responses to Environmental Stimuli During Homeostasis and Disease
    Adil Rasheed, Katey J. Rayner · 2021 · Endocrine Reviews
16. Control of Macrophage Inflammation by P2Y Purinergic Receptors
    Dominik Klaver, Martin Thurnher · 2021 · Cells
17. Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital
    Juan Vicente Mulet Bayona, Nuria Tormo, Carme Salvador García, Begoña Fuster, M Chanzá, P García, Concepción Gimeno Cardona · 2021 · Journal of Fungi
18. Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
    Munawara, Usma, Catanzaro, Michael, Xu, Weili, Tan, Crystal, Hirokawa, Katsuiku, Bosco, Nabil, Dumoulin, David, Khalil, Abdelouahed, Larbi, Anis, Lévesque, Simon et al. · 2021 · Immunity & Ageing
19. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
    Chiara Giacomelli, Rebecca Piccarducci, Laura Marchetti, Chiara Romei, Claudia Martini · 2021 · Biochemical Pharmacology
20. COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies
    Nafisa Ahmed, Maiesha Samiha Mahmood, Md. Asad Ullah, Yusha Araf, Tanjim Ishraq Rahaman, Abu Tayab Moin, Mohammad Jakir Hosen · 2022 · Current Microbiology
21. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient
    Béla Nagy, Zsolt Fejes, Zoltán Szentkereszty, Renáta Sütő, István Zsolt Várkonyi, Éva Ajzner, János Kappelmayer, Zoltán Papp, Attila Tóth, Miklós Fagyas · 2020 · International Journal of Infectious Diseases
22. EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection
    Mukesh Chourasia, Purushotham Reddy Koppula, Aruna Battu, Madhu Micheal Ouseph, Anil Singh · 2021 · Molecules
23. Negative Association Between Mediterranean Diet Adherence and COVID-19 Cases and Related Deaths in Spain and 23 OECD Countries: An Ecological Study
    Michael W. Greene, Alexis Roberts, Andrew D. Frugé · 2021 · Frontiers in Nutrition
24. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
    Shobi Veleri · 2021 · Experimental Brain Research
25. CD127 imprints functional heterogeneity to diversify monocyte responses in inflammatory diseases
    Bin Zhang, Yuan Zhang, Lei Xiong, Yuzhe Li, Yunliang Zhang, Jiuliang Zhao, Hui Jiang, Can Li, Yunqi Liu, Xindong Liu et al. · 2021 · The Journal of Experimental Medicine
26. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages
    Ioanna Pantazi, Ahmed Ali Al-Qahtani, Fatimah S. Alhamlan, Hani Alothaid, Sabine Matou‐Nasri, George Sourvinos, Eleni Vergadi, Christos Tsatsanis · 2021 · Frontiers in Immunology
27. The transcription factor EGR2 is indispensable for tissue-specific imprinting of alveolar macrophages in health and tissue repair
    Jack McCowan, Frédéric Fercoq, Phoebe M. Kirkwood, Wouter T’Jonck, Lizi M. Hegarty, Connar M. Mawer, Richard Cunningham, Ananda S. Mirchandani, Anna M. Hoy, Duncan C. Humphries et al. · 2021 · Science Immunology
28. Potential relationships between COVID-19 and the thyroid gland: an update
    Rania Naguib · 2022 · Journal of International Medical Research
29. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship
    Damiano D’Ardes, Andrea Boccatonda, Giulio Cocco, Stefano Fabiani, Ilaria Rossi, Marco Bucci, Maria Teresa Guagnano, Cosima Schiavone, Francesco Cipollone · 2022 · World Journal of Gastroenterology
30. A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses
    Yucheng Zheng, Shiliang Li, Kun Song, Jiajia Ye, Wenkang Li, Yifan Zhong, Ziyan Feng, Simeng Liang, Zeng Cai, Ke Xu · 2022 · Viruses
31. Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis
    Hasan Halit Öz, Ee-chun Cheng, Caterina Di Pietro, Toma Tebaldi, Giulia Biancon, Caroline J. Zeiss, Pingxia Zhang, Pamela H. Huang, Sofia S. Esquibies, Clemente J. Britto et al. · 2022 · Cell Reports
32. Immunity to fungi in the lung
    Lena J. Heung, Darin L. Wiesner, Keyi Wang, Amariliz Rivera, Tobias M. Hohl · 2023 · Seminars in Immunology
33. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series
    Pauline Vetter, Christiane Sigrid Eberhardt, Benjamin Meyer, Paola Martinez-Murillo, Giulia Torriani, Fiona Pigny, Sylvain Lemeille, Samuel Cordey, Florian Laubscher, Diem‐Lan Vu et al. · 2020 · mSphere
34. Unique properties of tissue-resident memory T cells in the lungs: implications for COVID-19 and other respiratory diseases
    Francis R. Carbone · 2022 · Nature reviews. Immunology
35. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release
    Junqueira, Caroline, Crespo, Ângela, Ranjbar, Shahin, Ingber, Jacob, Parry, Blair, Ravid, Sagi, Lacerda, Luna B. de, Lewandrowski, Mercedes, Clark, Sarah, Ho, Felicia et al. · 2021
36. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies
    Ting Zhou, Tina Tianjiao Su, Tenny Mudianto, Jun Wang · 2020 · The Journal of Experimental Medicine
37. Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID‐19): Are they similar?
    Saverio Paltrinieri, Alessia Giordano, Angelica Stranieri, Stefania Lauzi · 2020 · Transboundary and Emerging Diseases
38. Perspective: The Potential Effects of Naringenin in COVID-19
    Ricardo Wesley Alberca, Franciane Mouradian Emidio Teixeira, Danielle Rosa Beserra, Emily Araujo de Oliveira, Milena Mary de Souza Andrade, Anna Julia Pietrobon, Maria Notomi Sato · 2020 · Frontiers in Immunology
39. Current Status and Future Prospects of Perinatal Stem Cells
    Paz de la Torre, Ana Isabel Flores · 2020 · Genes
40. Leading Factors for Weight Gain during COVID-19 Lockdown in a Spanish Population: A Cross-Sectional Study
    Enric Sánchez, Albert Lecube, Diego Bellido, Susana Monereo, Marı́a M. Malagón, Francisco José Tinahones, on behalf of the Spanish Society for the Study of Obesity · 2021 · Nutrients
41. Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
    Seodhna M. Lynch, Guangran Guo, David S. Gibson, Anthony J. Bjourson, Taranjit Singh · 2021 · Cells
42. Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19
    Paula Rossini Augusti, Greicy M. M. Conterato, Cristiane Casagrande Denardin, Inês D. Prazeres, Teresa Serra, Maria Rosário Bronze, Tatiana Emanuelli · 2021 · The Journal of Nutritional Biochemistry
43. SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases
    Avaniyapuram Kannan Murugan, Ali Saeed Alzahrani · 2021 · Journal of Inflammation Research
44. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
    Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, Sanaz Hassani, Michał Sekrecki, Hanna Nowicka, Natalia Łopacinska, Arta Olya, Katarzyna Kluzek, Joanna Wesoły et al. · 2022 · Frontiers in Immunology
45. Innate immune evasion by SARS‐CoV ‐2: Comparison with SARS‐CoV
    Abdellatif Bouayad · 2020 · Reviews in Medical Virology
46. Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: A systematic review and meta-analysis
    Daniel Martin Simadibrata, Bashar Adi Wahyu Pandhita, Muammar Emir Ananta, Tamara Tango · 2020 · Journal of the Intensive Care Society
47. Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages—Potential Implications for Cytokine Storm Syndrome
    Iwona Karwaciak, Anna Sałkowska, Kaja Karaś, Jarosław Dastych, Marcin Ratajewski · 2021 · Vaccines
48. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection
    Mar Pacheco‐Herrero, Luis Oskar Soto-Rojas, Charles R. Harrington, Yazmin Montserrat Flores-Martinez, Marcos M. Villegas-Rojas, Alfredo M. León-Aguilar, Paola A. Martínez-Gómez, B. Berenice Campa-Córdoba, Ricardo Apátiga-Pérez, Carolin N. Corniel-Taveras et al. · 2021 · Frontiers in Neurology
49. Different aspects of frailty and COVID-19: points to consider in the current pandemic and future ones
    Hani Hussien, Andra Nastasa, Mugurel Apetrii, Ionuţ Nistor, Mirko Petrović, Adrian Constantin Covic · 2021 · BMC Geriatrics
50. Autoimmunity as the comet tail of COVID-19 pandemic
    Rossella Talotta, Erle S. Robertson · 2020 · World Journal of Clinical Cases
51. SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium
    Anne Zebitz Eriksen, Rasmus Møller, Bar Makovoz, Skyler A. Uhl, Benjamin Robert tenOever, Timothy A. Blenkinsop · 2021 · Cell stem cell
52. Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals
    Anuradha Rajamanickam, Nathella Pavan Kumar, Arul Nancy, Nandhini Selvaraj, Saravanan Munisankar, Rachel Mariam Renji, Vijayalakshmi Venkatramani, Manoj Vasanth Murhekar, Jeromie Wesley Vivian Thangaraj, Muthusamy Santhosh Kumar et al. · 2021 · Scientific Reports
53. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone
    Olumayokun A. Olajide, Victoria U. Iwuanyanwu, Izabela Lepiarz‐Raba, Alaa A Al‐Hindawi · 2021 · Inflammation
54. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease
    Berta Canal, Ryo Fujisawa, Allison W. McClure, Tom D Deegan, Mary Wu, Rachel Ulferts, Florian Weissmann, Lucy S. Drury, Agustina P. Bertolin, Jingkun Zeng et al. · 2021 · Biochemical Journal
55. Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19
    Duco Steven Koenis, Issa Beegun, Charlotte Camille Jouvene, Gabriel A. Aguirre, Patricia R. Souza, Maria Gonzalez-Nuñez, Lucy Ly, Kimberly Pistorius, Hemant Mahendrakumar Kocher, William Martin Ricketts et al. · 2021 · Circulation Research
56. One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents
    Jie Zhang, Hao Lin, Beiwei Ye, Min Jie Zhao, Jianbo Zhan, Shaobo Dong, Yaxin Guo, Yingze Zhao, Min Li, Sai Liu et al. · 2021 · Clinical Infectious Diseases
57. Role of microRNAs in COVID-19 with implications for therapeutics
    Nahid Arghiani, Tracy A Nissan, Maryam Moghaddam Matin · 2021 · Biomedicine & Pharmacotherapy
58. Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table
    Mitra Ranjbar, Ali R. Rahimi, Zeinab Baghernejadan, Atousa Ghorbani, Hossein Khorramdelazad · 2022 · International Immunopharmacology
59. Recent development in multizonal scaffolds for osteochondral regeneration
    Le Yu, Sacha Cavelier, Brett Hannon, Mei Wei · 2023 · Bioactive Materials
60. SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy
    Shuxin Liang, Changlei Bao, Zi F. Yang, Shiyun Liu, Yanan Sun, Weitao Cao, Ting Wang, Tae-Hwi Linus Schwantes-An, John S. Choy, Samisubbu R. Naidu et al. · 2023 · Signal Transduction and Targeted Therapy
61. Altitude and COVID‐19: Friend or foe? A narrative review
    Grégoire Paul Millet, Tadej Debevec, Franck Brocherie, Martin Burtscher, Johannes Burtscher · 2020 · Physiological Reports
62. The coronavirus disease (COVID-19) – A supportive approach with selected micronutrients
    Uwe Gröber, Michael F. Holick · 2021 · International Journal for Vitamin and Nutrition Research
63. A proteomic survival predictor for COVID-19 patients in intensive care
    Vadim Demichev, Pinkus Tober‐Lau, Tatiana Nazarenko, Oliver Lemke, Simran Kaur Aulakh, Harry J. Whitwell, Annika Röhl, Anja Freiwald, Mirja Mittermaier, Łukasz Szyrwiel et al. · 2022 · PLOS Digital Health
64. CISH impairs lysosomal function in activated T cells resulting in mitochondrial DNA release and inflammaging
    Jun Jin, Yunmei Mu, Huimin Zhang, Ines Sturmlechner, Chenyao Wang, Rohit R. Jadhav, Qiong Xia, Cornelia M. Weyand, Jörg J. Goronzy · 2023 · Nature Aging
65. Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
    Ligong Lu, Hui Zhang, Meixiao Zhan, Jun Jiang, Hua Yin, Danielle J. Dauphars, Shi-You Li, Yong Li, You-Wen He · 2020 · Frontiers in Cell and Developmental Biology
66. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
    Anna Maria Fratta Pasini, Chiara Stranieri, Luciano Cominacini, Chiara Mozzini · 2021 · Antioxidants
67. SARS-CoV-2 takes its Toll
    Alan Sariol, Stanley M. Perlman · 2021 · Nature Immunology
68. Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients
    Eduardo Cervantes‐Alvarez, Nathaly Limon‐de la Rosa, Moisés Salgado-de la Mora, Paola I. Valdez-Sandoval, Mildred Palacios-Jiménez, Fátima Rodríguez-Álvarez, Brenda I. Vera-Maldonado, Eduardo Aguirre-Aguilar, Juan Manuel Escobar-Valderrama, Jorge Alanis-Mendizabal et al. · 2022 · Scientific Reports
69. Immunosenescence and inflamm-ageing in COVID-19
    Mohammad Reza Zinatizadeh, Peyman Kheirandish Zarandi, Mohsen Ghiasi, Hamid Kooshki, Mozafar Mohammadi, Jafar Amani, Nima Rezaei · 2022 · Ageing Research Reviews
70. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System
    Matthew A. Sparks, Andrew Michael South, Andrew D. Badley, Carissa Marrie Baker-Smith, DANIEL C. BATLLE, Biykem Bozkurt, Roberto Cattaneo, Steven D. Crowley, Louis J. Dell’Italia, Andria L. Ford et al. · 2020 · Hypertension
71. Viral infection and smell loss: The case of COVID‐19
    Isaías Glezer, Alexandre Bruni‐Cardoso, Deborah Schechtman, Bettina Malnic · 2020 · Journal of Neurochemistry
72. A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study
    Joachim Linssen, A. A. M. Ermens, Marvin A. H. Berrevoets, Michela Seghezzi, Giulia Previtali, Simone van der Sar–van der Brugge, Henk Russcher, Annelies Verbon, Judith Gillis, Jürgen Riedl et al. · 2020 · eLife
73. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state
    Antonio Vitiello, Francesco Ferrara · 2021 · Respiratory Medicine
74. The central role of mitochondrial fitness on antiviral defenses: An advocacy for physical activity during the COVID-19 pandemic
    Johannes Burtscher, Martin Burtscher, Grégoire Paul Millet · 2021 · Redox Biology
75. Regulation of acute reflectory hyperinflammation in viral and other diseases by means of stellate ganglion block. A conceptual view with a focus on Covid-19
    Lorenz Fischer, Hans Barop, Sabina Maria Ludin, Hans‐Georg Schaible · 2021 · Autonomic Neuroscience
76. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
    Benjamin A Fisher, Tonny Veenith, Daniel Slade, Charlotte Gaskell, Matthew J. Rowland, Tony Whitehouse, James E. Scriven, Dhruv Parekh, Madhu S Balasubramaniam, Graham Cooke et al. · 2021 · The Lancet Respiratory Medicine
77. Recruited atypical Ly6G + macrophages license alveolar regeneration after lung injury
    Cecilia Ruscitti, Joan Abinet, Pauline Maréchal, Margot Meunier, Constance De meeûs, Domien Vanneste, Pierre Janssen, Mickaël Dourcy, Marc Thiry, Fabrice Bureau et al. · 2024 · Science Immunology
78. Mesenchymal stem cell immunomodulation: in pursuit of controlling COVID-19 related cytokine storm
    Song, Na, Wakimoto, Hiroaki, Rossignoli, Filippo, Bhere, Deepak, Ciccocioppo, Rachele, Chen, Kok-Siong, Khalsa, Jasneet Kaur, Mastrolia, Ilenia, Samarelli, Anna Valeria, Dominici, Massimo et al. · 2021 · Stem Cells
79. Pro‐Peptide‐Reinforced, Mucus‐Penetrating Pulmonary siRNA Delivery Mitigates Cytokine Storm in Pneumonia
    Jiandong Yang, Shanzhou Duan, Huan Ye, Chenglong Ge, Chunxian Piao, Yongbing Chen, Minhyung Lee, Lichen Yin · 2021 · Advanced Functional Materials
80. Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation
    Federico Virga, Federica Cappellesso, Benoı̂t Stijlemans, Anne‐Theres Henze, Rosa Trotta, Jonas R.M. Van Audenaerde, Ananda S. Mirchandani, Manuel A. Sánchez-García, Jolien Vandewalle, Francesca Orso et al. · 2021 · Science Advances
81. COVID-19 and ethnicity: A novel pathophysiological role for inflammation
    Abhinav Vepa, Joseph P. Bae, Faheem Ahmed, Manish Pareek, Kamlesh K. Khunti · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
82. Conflicts over calcium and the treatment of COVID-19
    Bernard J. Crespi, Joe Alcock · 2020 · Evolution Medicine and Public Health
83. SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia
    Ismaı̈l Elalamy, Grigoris Gerotziafas, Sonia Alamowitch, Jean-Pierre Laroche, Patrick Van Dreden, Walter Ageno, Jan Beyer‐Westendorf, Alexander Thomas Cohen, David Jiménez, Benjamin Brenner et al. · 2021 · Thrombosis and Haemostasis
84. Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
    C. Joaquín Cáceres, Stivalis Cardenas Garcia, Silvia Carnaccini, Brittany Seibert, Daniela S. Rajão, Jun Wang, Daniel Roberto Perez · 2021 · Scientific Reports
85. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19
    Salvatore Chirumbolo, Luigi Valdenassi, Vincenzo Simonetti, Dario Bertossi, Giovanni Ricevuti, Marianno Franzini, Sergio Pandolfi · 2021 · International Immunopharmacology
86. Role of Selenium in Viral Infections with a Major Focus on SARS-CoV-2
    Sabrina Sales Martínez, Yongjun Huang, Leonardo Acuna, Eduardo E. Laverde, David Trujillo, Manuel Alejandro Barbieri, Javier A. Tamargo, Adriana L. Campa, Marianna K. Baum · 2021 · International Journal of Molecular Sciences
87. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
    Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, Behzad Aria, Behzad Hemati, Farhang Fatehi, Hamid Ghaem Maghami Farahani, Ghazaleh Javanmard, Mahsa Rezaee, John Patrick Kastelic et al. · 2021 · Frontiers in Immunology
88. Innate immune responses in pneumonia
    Filiz T. Korkmaz, Katrina E. Traber · 2023 · Pneumonia
89. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients
    Xiang-Na Zhao, Yue You, Xiaoming Cui, Huixia Gao, Guolin Wang, Shengbo Zhang, Yao Lin, Li‐Jun Duan, Ka-Li Zhu, Yuling Wang et al. · 2021 · Signal Transduction and Targeted Therapy
90. Taming the Autophagy as a Strategy for Treating COVID-19
    Blanca Estela García‐Pérez, Juan Antonio González-Rojas, Ma Isabel Salazar, C. Torres-Torres, Nayeli Shantal Castrejón-Jiménez · 2020 · Cells
91. The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial
    Zhijian Luo, Wei Chen, Mingqing Xiang, Hua Wang, Wei Lie Xiao, Xu Cheng, Yunkui Li, Jie Min, Qiang Tu · 2021 · European Journal of Integrative Medicine
92. Exercise and sports after COVID‐19—Guidance from a clinical perspective
    Martin Halle, Wilhelm Bloch, Andreas Michael Niess, Hans‐Georg Predel, Claus Reinsberger, Jürgen Scharhag, Jürgen Michael Steinacker, Bernd Wolfarth, Johannes Scherr, Josef Niebauer · 2021 · Translational Sports Medicine
93. Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series
    Luis García de Guadiana‐Romualdo, María Dolores Rodríguez Mulero, Marta Hernández Olivo, Carlos Rodríguez Rojas, Verónica Ramos-Arenas, Mercedes González Morales, Ana Blázquez-Abellán, Pablo Conesa‐Zamora, Josefina García-García, Andrés Conesa Hernández et al. · 2020 · Journal of Infection
94. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection
    Andrea T. Obi, Geoffrey D. Barnes, Lena M. Napolitano, Peter K. Henke, Thomas W. Wakefield · 2020 · Journal of Vascular Surgery Venous and Lymphatic Disorders
95. Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation
    Lawson COVID19 Study Team, Sean E. Gill, Claúdia C. dos Santos, David B. O’Gorman, David E. Carter, Eric K. Patterson, Marat Slessarev, Claudio M. Martin, Mark Daley, Michael R. Miller et al. · 2020 · Intensive Care Medicine Experimental
96. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots
    Moon Ley Tung, Bryce W. Q. Tan, Robin Cherian, Bharatendu Chandra · 2021 · Rheumatology Advances in Practice
97. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
    Amal Hasan, Ebaa Al‐Ozairi, Zahraa Albaqsumi, Rasheed Ahmad, Fahd Al‐Mulla · 2021 · ImmunoTargets and Therapy
98. Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy?
    Georges Azar, Sophie Bonnin, Vivien Vasseur, Céline Faure, Flore Salviat, Catherine Vignal‐Clermont, Chérif Titah, Selim Farès, Élise Boulanger-Scemama, Sabine Derrien et al. · 2021 · Journal of Clinical Medicine
99. Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages
    Sina Bohnacker, Franziska Hartung, Fiona D. R. Henkel, Alessandro Quaranta, Johan Kolmert, Alina Priller, Minhaz Ud‐Dean, Johanna Giglberger, Luisa M. Kugler, Lisa Pechtold et al. · 2022 · Mucosal Immunology
100. A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
     Jatin Patel, Damon Bass, Albertus Beishuizen, Xavier Bocca Ruiz, Hatem Boughanmi, Anthony P. Cahn, Hugo R. Colombo, Gerard J. Criner, Katherine Davy, Javier de Miguel‐Díez et al. · 2022 · European Respiratory Journal